SCHEMBL790851

SCHEMBL790851

CC(O)N(c1nc(Nc2ccccc2)nc(Nc2ccc(C=Cc3ccc(Nc4nc(Nc5ccccc5)nc(N(C(C)O)C(C)O)n4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)n1)C(C)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.41
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
NSD2 O96028 1/20 0.38
DUSP3 P51452 1/20 0.38
PTPN5 P54829 1/20 0.38
CASP7 P55210 1/20 0.38
CASP6 P55212 1/20 0.38
PTPN11 Q06124 1/20 0.38
KCNH3 Q9ULD8 5/20 0.38
ALDH1A1 P00352 1/20 0.38
SNCA P37840 1/20 0.38
RHOA P61586 1/20 0.38
CHAT P28329 4/20 0.37
TNNI3 P19429 1/20 0.37
TNNT2 P45379 1/20 0.37
TNNC1 P63316 1/20 0.37
HKDC1 Q2TB90 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL16010164 0.99 ENPP2 (0.41) ENPP2CA12CA1CA2CA9
SCHEMBL7897023 0.99 ENPP2 (0.41) ENPP2CA12CA1CA2CA9
Ammonia Solution, Strong SCHEMBL16010169 0.99 ENPP2 (0.41) ENPP2CA12CA1CA2CA9
SCHEMBL1536960 0.95 CA12 (0.43) ENPP2CA12CA1CA2CA9
SCHEMBL1536137 0.94 CASP6 (0.44) ENPP2CA12CA1CA2CA9
SCHEMBL1041904 0.92 ENPP2 (0.41) ENPP2CA12CA1CA2CA9
SCHEMBL1536178 0.91 KCNH3 (0.40) CA12CA1CA2CA9KCNH3
SCHEMBL16374880 0.91 CHAT (0.43) ENPP2CA12CA1CA2CA9
SCHEMBL893620 0.91 RAD51 (0.47) CA12CA1CA2CA9KCNH3
SCHEMBL16374885 0.89 CA1 (0.48) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1067 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200032171-A1 Laundry Method, Use of Polypeptide and Detergent Composition NOVOZYMES A/S (DK) 2020-01-30 US claimed
US-20150064773-A1 Detergent Composition and Substitution of Optical Brighteners in Detergent Composition NOVOZYMES AS (DK) 2015-03-05 US claimed
EP-2823026-A1 DETERGENT COMPOSITION AND SUBSTITUTION OF OPTICAL BRIGHTENERS IN DETERGENT COMPOSITIONS Novozymes A/S (DK) 2015-01-14 EP claimed
WO-2013131964-A1 DETERGENT COMPOSITION AND SUBSTITUTION OF OPTICAL BRIGHTENERS IN DETERGENT COMPOSITIONS NOVOZYMES A/S (DK) 2013-09-12 WO claimed
EP-0578872-B1 Detergent compositions PROCTER & GAMBLE (US) 1998-10-14 EP claimed
US-20240228913-A1 ENZYME COMPOSITIONS AND USES THEREOF NOVOZYMES A/S (DK) 2024-07-11 US disclosed
EP-3362556-B1 POLYPEPTIDE VARIANTS NOVOZYMES AS (DK) 2024-07-10 EP disclosed
US-20240218299-A1 CLEANING COMPOSITIONS CONTAINING DISPERSINS II HENKEL AG & CO. KGAA (DE) 2024-07-04 US disclosed
US-20240209340-A1 Polypeptides having Peptidoglycan Degrading Activity and Polynucleotides Encoding Same NOVOZYMES A/S (DK) 2024-06-27 US disclosed
US-20240209335-A1 Cleaning Compositions Comprising Enzymes NOVOZYMES A/S (DK) 2024-06-27 US disclosed
US-12018236-B2 Detergent composition NOVOZYMES A/S (DK) 2024-06-25 US disclosed
WO-2024126483-A1 IMPROVED LIPASE (GCL1) VARIANTS NOVOZYMES A/S (DK) 2024-06-20 WO disclosed
EP-1867708-A1 Detergent Compositions The Procter and Gamble Company (US) 2007-12-19 EP disclosed
EP-1867707-A1 Detergent compositions The Procter and Gamble Company (US) 2007-12-19 EP disclosed
US-20060089283-A1 Pectate lyase variants NOVOZYMES A/S (DK) 2006-04-27 US disclosed
US-20030092097-A1 CELLULASE VARIANTS NOVOZYME A/S 2003-05-15 US disclosed
US-6153375-A MAKING COMBINATORIAL LIBRARIES BY USING SPECIFIC SOLID SUPPORT AND THEN REPEATEDLY ADDING REAGENT, RECORDING IDENTIFY OF ZONES, AND SUBDIVIDING BATCHES CAMBRIDGE COMBINATORIAL LIMITED (GB) 2000-11-28 US disclosed
US-6015783-A MODIFIED ENZYME (ENZYME HYBRID) WHICH COMPRISES A CATALYTICALLY ACTIVE AMINO ACID SEQUENCE OF A NON-CELLULOLYTIC ENZYME LINKED TO AN AMINO ACID SEQUENCE COMPRISING A CELLULOSE-BINDING DOMAIN. NOVO NORDISK A/S (DK) 2000-01-18 US disclosed
US-4536314-A PLEASANT ODOR THE PROCTER & GAMBLE COMPANY (US) 1985-08-20 US disclosed
US-4036778-A Aqueous, storage-stable dispersions of water-soluble compounds CIBA-GEIGY CORPORATION (US) 1977-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089283-A1 Pectate lyase variants MGAM, LCT, AGL ENPP2 2473/4885CA12 886/4885CA1 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.